AMETEK, Inc.

The forensic screens point in different directions, so readers may want to weigh them together rather than singly. The Beneish M-Score is -2.534, which is below the -1.78 threshold and therefore not in the elevated manipulation-risk zone. This is a screening model that compares receivables, margins, and asset quality year over year, and a clean reading is not proof that the numbers are accurate. The Altman Z″-Score of 5.41 falls in the safe zone (2.60 or above), which suggests low financial distress risk under that model. The Piotroski F-Score is 7 of 8 computable signals, a checklist covering profitability, leverage, and operating efficiency. The Fog Index of 19.59 is above 18, which the label places in the very hard to read band, so the MD&A narrative is harder to check than the financial statements. Operating cash flow divided by net income of 1.22 means cash generation still exceeds reported earnings, though the ratio is lower than the prior year's level. The 2025 balance sheet shows total assets of $16.07 billion, liabilities of $5.44 billion, and equity of $10.63 billion, up from $9.66 billion. Long-term debt fell to $1.07 billion from $1.43 billion. The Q2 2026 repurchase table shows no shares bought under the $1.25 billion authorization, with about $798.9 million remaining; only 724 shares were surrendered for employee tax withholding. Item 4 concludes disclosure controls are effective and reports no material change in internal control. Readers may want to look at the risk-factor discussion of Operational Excellence initiatives, the 48.2% international sales share, and the 22-country manufacturing footprint, since the forward-looking claims depend on execution in those areas.

Catalyst.Per the 2025 annual figures, AMETEK's revenue rose 6.6% to $7.4 billion from $6.94 billion in 2024, and operating income climbed to $1.91 billion from $1.78 billion. Net income reached $1.48 billion, up from $1.38 billion. The MD&A excerpt provided for the 10-Q covering the period ended June 30, 2026 is mostly forward-looking-statement boilerplate and does not describe segment or product drivers, so the business momentum here rests on reported totals. Management's Operational Excellence cost initiatives are named in the risk factors as a source of expected efficiency gains.

Hidden risk.The most easily missed tension is cash conversion. Operating cash flow was $1.8 billion in 2025, down slightly from $1.83 billion in 2024, while net income rose to $1.48 billion. Operating cash flow divided by net income fell to 1.22 from about 1.33 the prior year, calculated from the 2024 figures. Separately, international sales were 48.2% of 2025 consolidated net sales, up from 47.4% in 2024, with manufacturing in 22 countries and exposure to tariffs, export controls, and anti-corruption laws that the risk factors describe. The MD&A's Fog Index of 19.59 is in the very hard to read band, so management's explanations of these items are harder to verify than the reported numbers.